Adi Livneh
Direktor/Vorstandsmitglied bei New N.I. Medical (2011) Ltd.
Aktive Positionen von Adi Livneh
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
New N.I. Medical (2011) Ltd.
New N.I. Medical (2011) Ltd. Medical SpecialtiesHealth Technology New N.I. Medical (2011) Ltd. provides a non-invasive cardiac output monitoring system called nicas, which helps manage hypertension, dialysis, and heart failure. The private company is based in Raanana, Israel and was founded in 2011. The system is easy to use, cost-effective, and provides accurate assessment of cardiovascular, respiratory, and fluid status. The Israeli company's flagship solution, nicas, is based on advanced, proprietary patented technology and is designed to be the preferred solution for various challenges in cardiovascular disease management. The CEO is Eyal Karev. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Adi Livneh
Ehemalige bekannte Positionen von Adi Livneh
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TEFRON LTD. | Präsident | 01.09.2008 | 17.11.2009 |
Statistik
International
Israel | 3 |
Operativ
President | 1 |
Director/Board Member | 1 |
Sektoral
Consumer Non-Durables | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TEFRON LTD. | Consumer Non-Durables |
Private Unternehmen | 1 |
---|---|
New N.I. Medical (2011) Ltd.
New N.I. Medical (2011) Ltd. Medical SpecialtiesHealth Technology New N.I. Medical (2011) Ltd. provides a non-invasive cardiac output monitoring system called nicas, which helps manage hypertension, dialysis, and heart failure. The private company is based in Raanana, Israel and was founded in 2011. The system is easy to use, cost-effective, and provides accurate assessment of cardiovascular, respiratory, and fluid status. The Israeli company's flagship solution, nicas, is based on advanced, proprietary patented technology and is designed to be the preferred solution for various challenges in cardiovascular disease management. The CEO is Eyal Karev. | Health Technology |
- Börse
- Insiders
- Adi Livneh
- Erfahrung